Cargando…

TBR-760, a Dopamine-Somatostatin Compound, Arrests Growth of Aggressive Nonfunctioning Pituitary Adenomas in Mice

TBR-760 (formerly BIM-23A760) is a chimeric dopamine (DA)-somatostatin (SST) compound with potent agonist activity at both DA type 2 (D2R) and SST type 2 (SSTR2) receptors. Studies have shown that chimeric DA-SST compounds are more efficacious than individual DA and/or SST analogues, either alone or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halem, Heather A, Hochgeschwender, Ute, Rih, Jeong Keun, Nelson, Richard, Johnson, G Allan, Thiagalingam, Arunthi, Culler, Michael D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375803/ https://www.ncbi.nlm.nih.gov/pubmed/32591776 http://dx.doi.org/10.1210/endocr/bqaa101

Ejemplares similares

OR06-02 TBR-760, a Chimeric Somatostatin-Dopamine Compound, Arrests Aggressive Non-Functioning Pituitary Adenoma Growth In Vivo
por: Halem, Heather A, et al.
Publicado: (2020)

Immunohistochemical Profile of Nonfunctioning Pituitary Adenomas
por: Solovey, Mariana, et al.
Publicado: (2021)

Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas
por: Kim, Jean, et al.
Publicado: (2020)

Nonfunctioning giant pituitary adenomas: Invasiveness and recurrence
por: Landeiro, José Alberto, et al.
Publicado: (2015)

Coexistence of arteriovenous malformation with nonfunctioning pituitary adenoma
por: Yılmaz, Baran, et al.
Publicado: (2015)

Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas
por: Takeshita, Kaori, et al.
Publicado: (2022)

BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas
por: Ibáñez-Costa, Alejandro, et al.
Publicado: (2017)

MON-467 Expression of Somatostatin Receptors in Aggressive Non-Functioning Pituitary Adenomas
por: Soto, Alfonso, et al.
Publicado: (2019)

Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas
por: Zhan, Xianquan, et al.
Publicado: (2014)

Nonfunctioning Pituitary Adenoma That Changed to a Functional Gonadotropinoma
por: Andino-Ríos, Gerson Geovany, et al.
Publicado: (2018)

Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas
por: Giuffrida, Giuseppe, et al.
Publicado: (2022)

Diagnosis and Treatment of Nonfunctioning Pituitary Adenomas with Thyroid Disorders
por: Wang, Xu, et al.
Publicado: (2023)

Incidental versus symptomatic nonfunctioning pituitary adenomas: Are they different?
por: Guerreiro, Vanessa, et al.
Publicado: (2023)

Growth Pattern and Prognostic Factors of Untreated Nonfunctioning Pituitary Adenomas
por: Hwang, Kihwan, et al.
Publicado: (2019)

Neuroendoscopic and microscopic transsphenoidal approach for resection of nonfunctional pituitary adenomas
por: Ding, Zhi-Quan, et al.
Publicado: (2019)

Heart Rate Variability in Postoperative Patients with Nonfunctioning Pituitary Adenoma
por: Ha, Jeonghoon, et al.
Publicado: (2021)

Treatment of Postsurgical Clinically Nonfunctioning Pituitary Adenomas Remnants With Cabergoline
por: Vieira, Marina C M, et al.
Publicado: (2021)

Clinical features and management of nonfunctioning giant pituitary adenomas causing hydrocephalus
por: Zhang, Danfeng, et al.
Publicado: (2018)

Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes
por: Yagnik, Garima, et al.
Publicado: (2019)

Free Mucosal Graft for Reconstruction after Nonfunctional Pituitary Adenoma Surgery
por: Pérez-López, Carlos, et al.
Publicado: (2020)

Changes in vascular supply pattern associated with growth of nonfunctioning pituitary adenomas
por: Ito, Miiko, et al.
Publicado: (2022)

Pituitary stone resulting in visual dysfunction and spontaneous rhinorrhea in nonfunctioning pituitary adenoma: illustrative case
por: Kanemitsu, Takuya, et al.
Publicado: (2021)

Dopamine Agonists for Pituitary Adenomas
por: Cooper, Odelia, et al.
Publicado: (2018)

Correction: Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes
por: Yagnik, Garima, et al.
Publicado: (2019)

BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma
por: Shi, Chengzhang, et al.
Publicado: (2020)

Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery?
por: Charleux, Thomas, et al.
Publicado: (2022)

Metabolic Characteristics and M2 Macrophage Infiltrates in Invasive Nonfunctioning Pituitary Adenomas
por: Lin, Kunzhe, et al.
Publicado: (2022)

Machine-Learning Prediction of Postoperative Pituitary Hormonal Outcomes in Nonfunctioning Pituitary Adenomas: A Multicenter Study
por: Fang, Yi, et al.
Publicado: (2021)

Pituitary Crooke Cell Adenoma: Two Cases of an Aggressive Pituitary Adenoma
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

The role of somatostatin analogues in treatment of TSH secreting pituitary adenomas
por: Zgliczyński, Wojciech, et al.
Publicado: (2013)

The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomas
por: Zhan, Xianquan, et al.
Publicado: (2010)

Body Image Disturbance in Acromegaly Patients Compared to Nonfunctioning Pituitary Adenoma Patients and Controls
por: Conaglen, Helen M., et al.
Publicado: (2015)

Smad3 and phospho-Smad3 are potential markers of invasive nonfunctioning pituitary adenomas
por: Liu, Chunhui, et al.
Publicado: (2016)

Transcriptome Analysis Identifies an Attenuated Local Immune Response in Invasive Nonfunctioning Pituitary Adenomas
por: Kim, Yong Hwy, et al.
Publicado: (2019)

Presentation, Management, and Outcomes of Nonfunctioning Pituitary Adenomas: An Experience from a Developing Country
por: Das, Bhagwan, et al.
Publicado: (2019)

Retinal Microvascular Alterations Detected by Optical Coherence Tomography Angiography in Nonfunctioning Pituitary Adenomas
por: Wang, Xuqian, et al.
Publicado: (2022)

Long-term Outcomes of Hypofractionated Stereotactic Radiotherapy for the Treatment of Perioptic Nonfunctioning Pituitary Adenomas
por: HATA, Aiko, et al.
Publicado: (2021)

Image-driven classification of functioning and nonfunctioning pituitary adenoma by deep convolutional neural networks
por: Li, Hongyu, et al.
Publicado: (2021)

Transcriptome Analysis Identifies an Attenuated Local Immune Response in Invasive Nonfunctioning Pituitary Adenomas
por: Kim, Yong Hwy, et al.
Publicado: (2020)

Genome-wide DNA Methylation Differences in Nonfunctioning Pituitary Adenomas With and Without Postsurgical Progression
por: Hallén, Tobias, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ef25i45nf3g0ibk1bt43792paf